Rwanda

The Rwanda Food and Drugs Authority (Rwanda FDA), established under Law No. 60/2018 of 22/08/2018 governing food and drugs in Rwanda, is the primary regulatory authority responsible for the registration, licensing, and post-market surveillance of health products including pharmaceuticals, medical devices, diagnostics, and digital health solutions. The Rwanda FDA operates under the Ministry of Health and requires all health products to undergo a formal product registration process before they may be legally marketed or distributed in Rwanda. Applicants must submit a dossier for technical review, and the authority conducts assessments covering quality, safety, and efficacy before granting a marketing authorization.

Submission dossiers are generally expected to conform to the Common Technical Document (CTD) format, and the Rwanda FDA increasingly aligns its review processes with the East African Community (EAC) harmonized regulatory frameworks and the African Union's African Medicines Regulatory Harmonization (AMRH) initiative. Applicants are required to appoint a local authorized representative or agent registered in Rwanda to facilitate regulatory correspondence and post-market obligations. Rwanda FDA has made notable progress in recent years by implementing an electronic submission and tracking system to improve transparency and reduce review timelines. The authority also recognizes approvals from stringent regulatory authorities (SRAs) such as the EMA, US FDA, and WHO Prequalification as supporting evidence, which can expedite the review process under a reliance or recognition pathway.

Public procurement of health products in Rwanda is centrally coordinated through the Ministry of Health (MoH) and executed primarily by the Rwanda Medical Supply (RMS), a government-owned entity responsible for the quantification, procurement, storage, and distribution of medicines, medical devices, and diagnostics to public health facilities across the country. Large-scale public tenders are governed by the Rwanda Public Procurement Authority (RPPA) under Law No. 12/2007 on public procurement, which mandates competitive bidding processes, transparency requirements, and value-for-money assessments. District hospitals and health centers receive supplies through the RMS distribution network, with procurement planning informed by national health program priorities and the Essential Medicines List (EML).

Beyond public channels, Rwanda's health sector benefits significantly from donor-funded procurement streams. Organizations such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, PEPFAR/USAID, Gavi the Vaccine Alliance, UNICEF, and the United Nations Population Fund (UNFPA) support the procurement of commodities including antiretrovirals, vaccines, rapid diagnostic tests, and reproductive health supplies, often channeled through international procurement agents or directly via government systems. The private sector, comprising private hospitals, clinics, and pharmacies, procures health products through registered local distributors and importers. Rwanda has articulated ambitions to strengthen domestic manufacturing capacity in line with the Africa Medicines Manufacturing Initiative and the EAC regional manufacturing agenda, and policies increasingly encourage local and regional sourcing where products meet quality standards, though formal local content preferences remain limited in scope compared to some other markets.